Menu

思力华能倍乐噻托溴铵喷雾剂药品使用说明书

Author: Medicalhalo
Release time: 2025-10-19 11:44:20

It contains two active substances, tiotropium bromide and olodaterol, both of which are long-acting bronchodilators. Tiotropium belongs to the anticholinergic subgroup; olodaterol belongs to the long-acting beta2 agonist subgroup.

Spiriva Respimat Tiotropium Spray helps adults with chronic obstructive pulmonary disease (COPD) breathe easier. COPD is a long-term lung disease that causes shortness of breath and coughing. Tiotropium Bromide Spray helps open the airways, making it easier for air to move in and out of the lungs. Normal use of Slivar Respiractiotropium Bromide Spray can also relieve persistent shortness of breath caused by the disease, helping to minimize the impact of the disease on daily life.

The recommended dose of Respimat Tiotropium Bromide Spray is: Respimat is effective 24 hours a day, so it only needs to be used once a day, and if possible, at the same time every day. Spray twice with each use.

Because adult chronic obstructive pulmonary disease (COPD) is a long-term condition, use Respimat every day, not just when you have breathing problems. Do not exceed recommended dosage.

The approval of Sliva's tiotropium bromide spray was based on data from two pivotal Phase III trials (TONADO-1, -2). The study involved more than 5,000 COPD patients. The data showed that compared with placebo, tiotropium bromide and olodaterol monotherapy, Slava Respimat's tiotropium bromide spray resulted in a statistically significant improvement in patients' lung function (FEV1) and had a similar safety profile to tiotropium bromide or olodaterol.

The therapeutic effect of Slivar Respipacia Tiotropium Bromide Spray is remarkable, but patients cannot blindly take this drug for treatment. The use of Slava Resembilation Tiotropium Bromide Spray will also produce certain side effects or adverse reactions. Before treatment, patients should go to the hospital for a detailed examination and strictly follow the doctor's diagnosis and treatment recommendations.

The above is the introduction about. If patients have other questions about the drug (such as drug price, purchasing channels, etc.), they can consult the medical companion travel service.

Recommended hot articles: /newsDetail/82226.html

[ 免责声明 ]  本页面内容来自公开渠道(如FDA官网、Drugs官网、原研药厂官网等),仅供持有医疗专业资质的人员用于医学药学研究参考,不构成任何治疗建议或药品推荐。所涉药品可能未在中国大陆获批上市,不适用于中国境内销售和使用。如需治疗,请咨询正规医疗机构。本站不提供药品销售或代购服务。